Inspire Medical Systems (INSP) Tops Q3 EPS by 58c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts INSP Hot Sheet
Join SI Premium – FREE
Inspire Medical Systems (NYSE: INSP) reported Q3 EPS of $0.38, $0.58 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $224.5 million versus the consensus estimate of $220.42 million.
GUIDANCE:
Inspire Medical Systems sees FY2025 EPS of $0.90-$1.00, versus the consensus of $0.99. Inspire Medical Systems sees FY2025 revenue of $900-910 million, versus the consensus of $903.6 million.
For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
- Graphano Energy amends private placement to add flow-through shares
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
